Table 1.

Cannabis use guidance among medical, retail, and both dispensaries who recommended products for nausea in pregnancy

Response from dispensary to “pregnant” caller	Overall	Medical License	Retail License	Medical and Retail License	P value*
Primary Outcome	n=400	n=148	n=111	n=141
Recommended cannabis†	69(64–74)	83(76–89)	60(51–70)	62(53–70)	<0.001
Secondary Outcomes	n=277	n=123	n=67	n=87
Report of recommendation for use based on:
Personal opinion	65(59–71)	85(77–90)	57(44–69)	45(34–56)	<0.001
Referenced research	6(3–9)	7(3–14)	3(0–10)	6(2–13)	0.46
Referenced dispensary policy	1(0–3)	1(0–5)	0(0–5)	1(0–6)	>0.99
Deferred to health care provider	3(1–6)	2(0–6)	0(0–5)	7(3–15)	0.014
Did not specify	30(24–35)	9(5–16)	40(28–53)	50(39–61)	<0.001
Reported safety of cannabis use:
Stated cannabis use safe	36(30–42)	41(32–50)	28(18–41)	34(25–45)	0.24
Potential for fetal harm	5(3–8)	4(1–9)	1(0–8)	8(3–16)	0.15
Potential for both fetal and maternal harm	2(1–4)	2(0–6)	4(1–13)	0(0–4)	0.11
Unsure or depends on certain criteria	53(47–59)	53(44–62)	55(43–67)	53(42–64)	0.95
Deferred to health care provider	15(11–20)	15(9–22)	15(7–26)	15(8–24)	>0.99

All data presented as percent (exact 95% CI). Responses are not mutually-exclusive.

^*P values for 3×2 comparisons using a Pearson exact chi-square.

^†Provides denominator for percentages in remainder of rows.